Study of factors affecting maternal and fetal outcome in HIV positive women


  • Sumitra Yadav Professor, Department of Obstetrics and Gynecology, Mahatma Gandhi Memorial Medical College Indore, Madhya Pradesh, India
  • Ruchi Joshi Senior Registrar, Department of Obstetrics and Gynecology, Mahatma Gandhi Memorial Medical College Indore, Madhya Pradesh, India
  • Vishal Kale Department of Pediatrics, Mahatma Gandhi Memorial Medical College Indore, Madhya Pradesh, India



ART, HIV, Pregnancy


Background: HIV virus infection was detected first time in India in Tamil Nadu in April 1986; India has the third largest HIV epidemic in the world. In 2013, HIV prevalence in India was an estimated 0.3 percent. The pregnant women and her unborn child who are HIV reactive are mostly innocent bearers of the brunt of the infection. Mother-to-child transmission of HIV is a major route of new infections in children. Without any intervention, the risk of transmission of HIV from infected pregnant women to her child is estimated to be around 20- 45%.Early diagnosis of children born to HIV positive mother using HIV DNA PCR and treating children who are diagnosed HIV-positive with antiretroviral drugs within their first 12 weeks of life reduces mortality by 75%.

Methods: This retrospective data analytic study of HIV positive pregnant women who attended antenatal clinic and delivered at M.Y. Hospital, Indore from January 2011 to December 2013 .For screening of ANC patients ELISA method was used. For the children, HIV DNA was done by sending the dried blood smear on blot paper and was sent to the reference laboratory Kasturba Hospital, Mumbai and used for diagnosis at 6 week and 6 month.

Results: Only 50% of HIV positive children were started on ART, 20% died, 20% loss to follow up and 10% were not willing for follow up. Also 30% mothers practiced mixed feeding. Neonatal mortality rate was 54.87 per thousand live births which is more than the seronegative mothers.

Conclusions: First HIV DNA testing can be done at 72 hours to detect antenatal HIV transmission. Early testing can pick up these cases early and ensure treatment. Mixed feeding should be strongly discouraged by counseling and modern methods of communication.


Centers for Disease Control and Prevention: AIDS Surveillance Trends, Slide Set. 2011.

Operative Guidelines for Lifelong ART for All Pregnant Women Living With HIV for Prevention of Parent to Child Transmission (PPTCT) of HIV in India, NACO, December 2013.

Koutis AP, Bultreys M, Nesheim SR. Understanding the Timing of HIV Transmission from Mother to Infant. JAMA. 2001;285:709.

Kourtis AP, Jamieson DJ, de Vincenzi I. Prevention of Human Immunodeficiency Virus 1 Transmission to the Infant through Breastfeeding: New Development. Am J Obstet Gynecol. 2007;197:S113.

Cotter AM, Brookfield KF, Duthely LM. Duration Of Membrane Rupture And Risk Of Perinatal Transmission Of HIV 1 In The Era Of Combination Antiretroviral Therapy. Am J Obstet Gynecol. 2012;207:482.

Panel on Treatment of HIV Infected Pregnant Women And Prevention Of Perinatal Transmission. Recommendation For Use of Antiretroviral Drugs In Pregnant HIV 1 Infected Woman For Maternal Health And Interventions To Reduce Perinatal HIV Transmission In United State. 2012.

Getting to Zero, UNAIDS 2011-2015 Strategy, Joint United Nations Programme On HIV/AIDS (UNAIDS)/10.12E / JC2034E. 2010.

Kennedy D. The effect of maternal HIV status on perinatal outcome at Mowbray Maternity Hospital and referring midwife obstetric units, Cape Town. SAJOG. 2012;18(1).

Pradhan BK, Sundar R. Socioeconomic impact of HIV and AIDS in India. United Nations Development Programme, 2006.

Ahir SP, Chavan V, Kerkar S. Antiretroviral treatment, viral load of mothers and perinatal HIV transmission in Mumbai, India. The Indian Journal of Medical Research. 2013;138(2):201-8.

Ahmed S, Kim MH, Abrams EJ. Risks and benefits of lifelong antiretroviral treatment for pregnant and breastfeeding women: a review of the evidence for the Option B+ approach. Curr Opin HIV AIDS. 2013;8:474-89.

Saharan S, Lodha R, Agarwal R. Perinatal HIV, AIIMS NICU Protocol, 2010.

HHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission. Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States. Rockville, MD: Department of Health and Human Services; 2012.

Kumar RM, Uduman SA, Khurranna AK. Impact of maternal HIV-1 infection on perinatal outcome. International Journal of Gynecology and Obstetrics. 1995;49(2):137-43.






Original Research Articles